Trials / Completed
CompletedNCT01957293
Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Prof. Dominique de Quervain, MD · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Aim is to investigate the effect of beta2 adrenergic stimulant salbutamol on emotional and cognitive functions in healthy humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salbutamol | single oral administration, 4 mg |
| DRUG | Placebo | single oral administration |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Completion
- 2014-02-01
- First posted
- 2013-10-08
- Last updated
- 2014-12-16
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01957293. Inclusion in this directory is not an endorsement.